Exclusive Investment Opportunity in Metaxchange.AI Inc.
Dear ,
We are excited to extend an exclusive invitation to accredited investors like yourself to participate in a unique investment opportunity with Metaxchange.AI Inc., listed in NASDAQ Private Market effective April 15, 2025.
Metaxchange.AI is revolutionizing the Digital Media Hub for the Malaysian Travel Industry, Food & Beverage Wholesale, and soon to be announced Cruise Travels and we are currently offering early access to our Pre-IPO shares. This is a remarkable opportunity to join a dynamic and rapidly growing company at the forefront of AI innovation.
Why Invest in Metaxchange.AI?
- NASDAQ Private Market Listing: As of April 15, 2025, Metaxchange.AI is listed on the NASDAQ Private Market, opening up new levels of visibility and investment opportunities.
- Proven Leadership & Vision: Our team consists of industry leaders committed to driving technological advancements and delivering value to our shareholders.
- Pre-IPO Investment Opportunity: By participating in our Pre-IPO round, you gain early access to shares at a highly favorable valuation before the public listing. You must be an accredited investor.
For More Information, Please Visit the Following Resources:
- Metaxchange.AI Website
- Investor Relations & PR - Pre-IPO Early Shares
- SEC Pre-IPO Filing
- AI Generated VCast
- Visit the METAXCHANGE Auto Webcast Room with AI Agent
We know you have many investments choice. We would be thrilled to have you among our 661 stakeholders. Join our ESG driven journey as we are a NASDAQ Private Market listed debut. Should you be interested in exploring this opportunity further, or if you have any questions, please do not hesitate to contact us.
We look forward to discussing how you can become part of the next big innovation in AI-driven financial markets.Warm regards,
MAXWELL RAND INC
C/O INVESTROOM.AI
Financial Tower
1 East Broward Blvd
Suite 700
Fort Lauderdale, FL. 33301 USA
Phone:(407) 520-2271
Email: compliance@metaxchangeai.com
No comments:
Post a Comment